While intermediate length expansions in the polyglutamine (polyQ) tract of ATXN2 were previously shown to be a risk factor for ALS [45], to date no one has asked if point mutations in the ATXN2 gene are linked to ALS. The gene discussed is ATXN2; the disease is amyotrophic lateral sclerosis.